Our data suggested that COVID-19-/IL-1β-driven PAI-1 and plasminogen activator (PA) upregulation enhanced PA/PAI-1 complex formation in the 4G4G genotype, trapping PAs and causing a fibrinolysis shutdown. This evidence concerns the gene IL1B and COVID-19.